Literature DB >> 10815129

Role of the low-density lipoprotein receptor-related protein in beta-amyloid metabolism and Alzheimer disease.

B T Hyman1, D Strickland, G W Rebeck.   

Abstract

Deposition of beta-amyloid (A beta), a metabolite of approximately 4 kd of the amyloid precursor protein, is a critical pathological feature in Alzheimer disease. We postulate that deposition reflects an imbalance of A beta synthesis and clearance. Several pathways that impact A beta converge on a single receptor molecule, the low-density lipoprotein receptor-related protein (LRP). This multifunctional receptor is the major neuronal receptor both for apolipoprotein E (apoE, protein; APOE, gene) and for alpha2-macroglobulin (alpha2M, protein; A2M, gene), and it mediates clearance of apoE/A beta and alpha2M/A beta complexes. The LRP also interacts with the amyloid precursor protein itself. In this review, we highlight data that support a role for LRP in A beta metabolism and hypothesize that LRP therefore plays a critical role in Alzheimer disease.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10815129     DOI: 10.1001/archneur.57.5.646

Source DB:  PubMed          Journal:  Arch Neurol        ISSN: 0003-9942


  22 in total

1.  The low-density lipoprotein receptor-related protein 1 (LRP1) mediates the endocytosis of the cellular prion protein.

Authors:  David R Taylor; Nigel M Hooper
Journal:  Biochem J       Date:  2007-02-15       Impact factor: 3.857

2.  The cytoplasmic domain of the LDL receptor-related protein regulates multiple steps in APP processing.

Authors:  Claus U Pietrzik; Tracy Busse; David E Merriam; Sascha Weggen; Edward H Koo
Journal:  EMBO J       Date:  2002-11-01       Impact factor: 11.598

3.  Engulfment adaptor phosphotyrosine-binding-domain-containing 1 (GULP1) is a nucleocytoplasmic shuttling protein and is transactivationally active together with low-density lipoprotein receptor-related protein 1 (LRP1).

Authors:  Anke Wahler; Anja-Silke Beyer; Ilona E Keller; Cathrin Schnack; Björn von Einem; Christian Pröpper; Tobias M Boeckers; Ithan D Peltan; Dudley K Strickland; Bradley T Hyman; Christine A F von Arnim
Journal:  Biochem J       Date:  2013-03-01       Impact factor: 3.857

4.  Lead-induced accumulation of beta-amyloid in the choroid plexus: role of low density lipoprotein receptor protein-1 and protein kinase C.

Authors:  Mamta Behl; Yanshu Zhang; Yunzhou Shi; Jixin Cheng; Yansheng Du; Wei Zheng
Journal:  Neurotoxicology       Date:  2010-05-19       Impact factor: 4.294

Review 5.  Statins and dementia.

Authors:  Lewis H Kuller
Journal:  Curr Atheroscler Rep       Date:  2007-08       Impact factor: 5.113

6.  Proteasome regulates the delivery of LDL receptor-related protein into the degradation pathway.

Authors:  Lora Melman; Hans J Geuze; Yonghe Li; Lynn M McCormick; Peter Van Kerkhof; Ger J Strous; Alan L Schwartz; Guojun Bu
Journal:  Mol Biol Cell       Date:  2002-09       Impact factor: 4.138

Review 7.  Linking vascular disorders and Alzheimer's disease: potential involvement of BACE1.

Authors:  Sarah L Cole; Robert Vassar
Journal:  Neurobiol Aging       Date:  2008-03-04       Impact factor: 4.673

8.  A dual role for apolipoprotein e in neuroinflammation: anti- and pro-inflammatory activity.

Authors:  Ling Guo; Mary Jo LaDu; Linda J Van Eldik
Journal:  J Mol Neurosci       Date:  2004       Impact factor: 3.444

9.  Increased beta-amyloid levels in the choroid plexus following lead exposure and the involvement of low-density lipoprotein receptor protein-1.

Authors:  Mamta Behl; Yanshu Zhang; Andrew D Monnot; Wendy Jiang; Wei Zheng
Journal:  Toxicol Appl Pharmacol       Date:  2009-06-06       Impact factor: 4.219

10.  The Basic Biology of BACE1: A Key Therapeutic Target for Alzheimer's Disease.

Authors:  S L Cole; R Vassar
Journal:  Curr Genomics       Date:  2007-12       Impact factor: 2.236

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.